• 29 Citations
  • 2 h-Index
20152018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Stacy A. Johnson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Diabetic Nephropathies Medicine & Life Sciences
Angiotensin Receptors Medicine & Life Sciences
Losartan Medicine & Life Sciences
Genetic Predisposition to Disease Medicine & Life Sciences
Angiotensin-Converting Enzyme Inhibitors Medicine & Life Sciences
Prostate Medicine & Life Sciences
Immunity Medicine & Life Sciences
Renin-Angiotensin System Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2015 2018

  • 29 Citations
  • 2 h-Index
  • 2 Article
  • 1 Review article
2 Citations (Scopus)

Inflammation and immunity pathways regulate genetic susceptibility to diabetic nephropathy

Gurley, S. B., Ghosh, S., Johnson, S. A., Azushima, K., Sakban, R. B., George, S. E., Maeda, M., Meyer, T. W. & Coffman, T. M., Oct 2018, In : Diabetes. 67, 10, p. 2096-2106 11 p.

Research output: Contribution to journalArticle

Diabetic Nephropathies
Genetic Predisposition to Disease
Immunity
Inflammation
Kidney Diseases

Angiotensin receptor signaling and prostate tumor growth in mice

Scott-Emuakpor, J., Allot, E., Johnson, S., Howard, L. E., Macias, E., Freedland, S. J. & Gurley, S. B., Jan 1 2015, In : Journal of Experimental Therapeutics and Oncology. 11, 2, p. 107-115 9 p.

Research output: Contribution to journalArticle

Angiotensin Receptors
Losartan
Prostate
Prostatic Neoplasms
Growth
26 Citations (Scopus)

Twenty years after ACEIs and ARBs: Emerging treatment strategies for diabetic nephropathy

Johnson, S. A. & Spurney, R. F., Jan 1 2015, In : American Journal of Physiology - Renal Physiology. 309, 10, p. F807-F820

Research output: Contribution to journalReview article

Diabetic Nephropathies
Angiotensin-Converting Enzyme Inhibitors
Chronic Kidney Failure
Therapeutics
Angiotensin Receptor Antagonists